TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02409238

Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study

Cause of deathStaffing, sites or logistics, also funding or business Automatic label, confidence 0.5, unverified. How labels are made.
“1. Limits of grant funding reached 2. A/Prof Ng Tze Pin (P.I. \& holder of NMRC Grant (CIRG12may033) funding this study) retired in Aug 2022. 3. Resignations of staff and collaborators especially over the 1st 2 years of the COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

2015201620172018201920202021Started2015-03-11Registered2015-03-26Stopped2019-12-31

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
SingHealth Polyclinics
Sponsor type
University, hospital or other
Conditions
Mild Cognitive Impairment; Insulin Resistance; Diabetes Mellitus, Type 2
Interventions
Metformin; Intensive Lifestyle Intervention; Standard LIfestyle Recommendation
Participants
105
Sites
1
Countries
Singapore

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.